Literature DB >> 19939855

ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry.

Xana Kim-Howard1, Amit K Maiti, Juan-Manuel Anaya, Gail R Bruner, Elizabeth Brown, Joan T Merrill, Jeffrey C Edberg, Michelle A Petri, John D Reveille, Rosalind Ramsey-Goldman, Graciela S Alarcon, Timothy J Vyse, Gary Gilkeson, Robert P Kimberly, Judith A James, Joel M Guthridge, John B Harley, Swapan K Nath.   

Abstract

PURPOSE: It was hypothesised that the coding variant (R77H), rs1143679, within ITGAM could predict specific clinical manifestations associated with systemic lupus erythematosus (SLE).
METHOD: To assess genetic association, 2366 patients with SLE and 2931 unaffected controls with European ancestry were analysed. The patients with SLE were coded by the presence or absence of individual American College of Rheumatology criteria. Logistic regression and Pearson chi(2) tests were used to assess statistical significance.
RESULTS: For overall case-control analysis, a highly significant association was detected (p=2.22x10-21, OR 1.73). Using case-only analysis, a significant association was detected with renal criteria (p=0.0003), discoid rash (p=0.02) and immunological criteria (p=0.04). When patients with SLE were compared with healthy controls, the association became stronger for renal (p=4.69x10-22, OR 2.15), discoid (p=1.77x10-14, OR 2.03) and immunological (p=3.49x10-22, OR 1.86) criteria. Risk allele frequency increased from 10.6% (controls) to 17.0% (SLE), 20.4% (renal), 18.1% (immunological) and 19.5% (discoid).
CONCLUSION: These results show a strong association between the risk allele (A) at rs1143679 and renal disease, discoid rash and immunological manifestations of SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939855      PMCID: PMC2891778          DOI: 10.1136/ard.2009.120543

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Monocytes and macrophages in focal glomerulosclerosis in Zucker rats.

Authors:  A B Magil; J J Frohlich
Journal:  Nephron       Date:  1991       Impact factor: 2.847

2.  The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus.

Authors:  Kathleen E Sullivan; April Suriano; Kelly Dietzmann; Janice Lin; Daniel Goldman; Michelle A Petri
Journal:  Clin Immunol       Date:  2007-02-05       Impact factor: 3.969

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Monocytes in human glomerulonephritis. An electron microscopic study.

Authors:  A B Magil; L D Wadsworth
Journal:  Lab Invest       Date:  1981-07       Impact factor: 5.662

5.  Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.

Authors:  M D Kazatchkine; D T Fearon; M D Appay; C Mandet; J Bariety
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis.

Authors:  V D D'Agati; G B Appel; D Estes; D M Knowles; C L Pirani
Journal:  Kidney Int       Date:  1986-10       Impact factor: 10.612

7.  Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.

Authors:  Murray B Urowitz; Dominique Ibañez; Yaser Ali; Dafna D Gladman
Journal:  J Rheumatol       Date:  2007-06-15       Impact factor: 4.666

8.  Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  A L Hepburn; J C Mason; K A Davies
Journal:  Rheumatology (Oxford)       Date:  2004-01-27       Impact factor: 7.580

9.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

10.  Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.

Authors:  Doreen Finke; Katharina Randers; Robert Hoerster; Holger Hennig; Rainer Zawatzky; Tony Marion; Christian Brockmann; Katja Klempt-Giessing; Kirsten Jacobsen; Holger Kirchner; Siegfried Goerg
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

View more
  36 in total

1.  CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.

Authors:  Mohd Hafeez Faridi; Samia Q Khan; Wenpu Zhao; Ha Won Lee; Mehmet M Altintas; Kun Zhang; Vinay Kumar; Andrew R Armstrong; Carmelo Carmona-Rivera; Jessica M Dorschner; Abigail M Schnaith; Xiaobo Li; Yogita Ghodke-Puranik; Erica Moore; Monica Purmalek; Jorge Irizarry-Caro; Tingting Zhang; Rachael Day; Darren Stoub; Victoria Hoffmann; Shehryar Jehangir Khaliqdina; Prachal Bhargava; Ana M Santander; Marta Torroella-Kouri; Biju Issac; David J Cimbaluk; Andrew Zloza; Rajeev Prabhakar; Shashank Deep; Meenakshi Jolly; Kwi Hye Koh; Jonathan S Reichner; Elizabeth M Bradshaw; JianFeng Chen; Luis F Moita; Peter S Yuen; Wanxia Li Tsai; Bhupinder Singh; Jochen Reiser; Swapan K Nath; Timothy B Niewold; Roberto I Vazquez-Padron; Mariana J Kaplan; Vineet Gupta
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

Review 2.  Using genetics to deliver personalized SLE therapy-a realistic prospect?

Authors:  Benjamin Rhodes; Timothy J Vyse
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

Review 3.  Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective.

Authors:  Ali Javinani; Amir Ashraf-Ganjouei; Saeed Aslani; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Immunogenetics       Date:  2019-01-22       Impact factor: 2.846

Review 4.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

Review 5.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

6.  Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM.

Authors:  Amit K Maiti; Xana Kim-Howard; Prasenjeet Motghare; Vandana Pradhan; Kek Heng Chua; Celi Sun; María Teresa Arango-Guerrero; Kanjaksha Ghosh; Timothy B Niewold; John B Harley; Juan-Manual Anaya; Loren L Looger; Swapan K Nath
Journal:  Hum Mol Genet       Date:  2014-03-07       Impact factor: 6.150

7.  Systemic lupus erythematosus diagnostics in the 'omics' era.

Authors:  Cristina Arriens; Chandra Mohan
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

Review 8.  Genetics of human lupus nephritis.

Authors:  Taro Iwamoto; Timothy B Niewold
Journal:  Clin Immunol       Date:  2016-09-28       Impact factor: 3.969

Review 9.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  Ornella Josephine Rullo; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

Review 10.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.